Replies to post #431145 on Amarin Corp Plc (AMRN)

[JRoon71]

North, I think you may be right.

And if you look at their verbiage on China, they only stated that Edding is "advancing efforts" for reimbursement in China. There was no mention of potential inclusion this year. Since NRDL negotiations were essentially completed when they made their presentation a few weeks ago, they already knew that Vascepa was not on the list for 2025.